GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Cyclically Adjusted Revenue per Share

OSSFF (Embla Medical hf) Cyclically Adjusted Revenue per Share : $1.84 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Embla Medical hf's adjusted revenue per share for the three months ended in Jun. 2024 was $0.511. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1.84 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Embla Medical hf was 12.70% per year. The lowest was 8.50% per year. And the median was 10.45% per year.

As of today (2024-09-21), Embla Medical hf's current stock price is $4.47. Embla Medical hf's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was $1.84. Embla Medical hf's Cyclically Adjusted PS Ratio of today is 2.43.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Embla Medical hf was 7.20. The lowest was 2.13. And the median was 4.45.


Embla Medical hf Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Embla Medical hf's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Cyclically Adjusted Revenue per Share Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 1.38 1.33 1.48 1.85

Embla Medical hf Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.71 1.79 1.85 1.66 1.84

Competitive Comparison of Embla Medical hf's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted PS Ratio falls into.



Embla Medical hf Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.511/147.2665*147.2665
=0.511

Current CPI (Jun. 2024) = 147.2665.

Embla Medical hf Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.279 98.734 0.416
201412 0.287 98.669 0.428
201503 0.255 99.612 0.377
201506 0.286 100.289 0.420
201509 0.254 100.607 0.372
201512 0.301 100.657 0.440
201603 0.257 101.115 0.374
201606 0.312 101.923 0.451
201609 0.294 102.457 0.423
201612 0.316 102.562 0.454
201703 0.302 102.768 0.433
201706 0.336 103.496 0.478
201709 0.322 103.871 0.457
201712 0.355 104.481 0.500
201803 0.334 105.600 0.466
201806 0.370 106.206 0.513
201809 0.337 106.727 0.465
201812 0.387 108.388 0.526
201903 0.392 108.702 0.531
201906 0.439 109.758 0.589
201909 0.409 109.922 0.548
201912 0.372 110.588 0.495
202003 0.393 111.019 0.521
202006 0.310 112.667 0.405
202009 0.418 113.772 0.541
202012 0.402 114.542 0.517
202103 0.390 115.833 0.496
202106 0.471 117.451 0.591
202109 0.442 118.723 0.548
202112 0.400 120.398 0.489
202203 0.427 123.555 0.509
202206 0.437 127.809 0.504
202209 0.418 129.810 0.474
202212 0.420 131.901 0.469
202303 0.447 135.674 0.485
202306 0.485 139.150 0.513
202309 0.458 140.147 0.481
202312 0.481 142.125 0.498
202403 0.460 144.910 0.467
202406 0.511 147.267 0.511

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Embla Medical hf  (OTCPK:OSSFF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.47/1.84
=2.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Embla Medical hf was 7.20. The lowest was 2.13. And the median was 4.45.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Embla Medical hf Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.